Enzalutamide with androgen deprivation therapy in Japanese men with metastatic hormone‐sensitive prostate cancer: A subgroup analysis of the phase III ARCHES study

OBJECTIVE: To evaluate the efficacy and safety of enzalutamide plus androgen deprivation therapy in Japanese men with metastatic hormone‐sensitive prostate cancer. METHODS: A post‐hoc analysis of the Japanese subgroup in the phase III, randomized, multinational ARCHES study (NCT02677896) was carried...

Descripción completa

Detalles Bibliográficos
Autores principales: Iguchi, Taro, Kimura, Go, Fukasawa, Satoshi, Suzuki, Hiroyoshi, Uemura, Hiroji, Nishimura, Kazuo, Matsumoto, Hiroaki, Yokomizo, Akira, Armstrong, Andrew J, Rosbrook, Brad, Sugg, Jennifer, Baron, Benoit, Chen, Lucy, Kunieda, Futoshi, Stenzl, Arnulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles: Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360194/
https://www.ncbi.nlm.nih.gov/pubmed/33955599
http://dx.doi.org/10.1111/iju.14568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360194/
https://www.ncbi.nlm.nih.gov/pubmed/33955599
http://dx.doi.org/10.1111/iju.14568

Ejemplares similares